213 results on '"Waite, Kristin"'
Search Results
2. Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
3. A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
4. Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions.
5. Racial disparities in breast cancer treatment patterns and treatment related adverse events
6. Author Correction: Federated learning enables big data for rare cancer boundary detection
7. Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex
8. Plasma IL13Rα2 as a novel liquid biopsy biomarker for glioblastoma
9. Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017
10. Epidemiology of primary malignant non-osseous spinal tumors in the United States
11. Sex differences in esophageal cancer overall and by histological subtype
12. Federated learning enables big data for rare cancer boundary detection
13. Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
14. Abstract 11546: Racial Disparities in Zip-Code Level Social Determinants of Health and Cardiovascular Outcomes in Females With Breast Cancer
15. Abstract 10355: Allostatic Load and Cardiovascular Outcomes in Males With Prostate Cancer
16. Abstract 10351: Racial Differences in Chronic Stress or Allostatic Load Variation Due to Androgen Deprivation Therapy in Prostate Cancer
17. CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020.
18. Sex Differences in Odds of Brain Metastasis and Outcomes by Brain Metastasis Status after Advanced Melanoma Diagnosis.
19. The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors.
20. Association of county-level socioeconomic status with meningioma incidence and outcomes.
21. Brain tumors in United States military veterans.
22. Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019.
23. Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations—An Exemplar in Brain Tumors
24. Critical Partnerships: How to Develop a Trans-Disciplinary Research Team.
25. Disease-Based Prognostication: Neuro-Oncology.
26. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020.
27. The impact of the COVID-19 pandemic on treatment patterns in glioblastoma.
28. Complete prevalence of primary malignant and nonmalignant brain tumors in comparison to other cancers in the United States.
29. Thirty-Day Unplanned Hospital Readmissions in Patients With Cancer and the Impact of Social Determinants of Health: A Machine Learning Approach.
30. National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
31. Allostatic load and cardiovascular outcomes in males with prostate cancer.
32. Racial Differences in Chronic Stress/Allostatic Load Variation Due to Androgen Deprivation Therapy in Prostate Cancer
33. Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival.
34. Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
35. Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States.
36. Incidence and survival of choroid plexus tumors in the United States.
37. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019.
38. Cell-Free Activation of Neutrophil NADPH Oxidase by a Phosphatidic Acid-Regulated Protein Kinase
39. CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018.
40. population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
41. Participation in Health Services/Population Health Research in US Departments of Medicine
42. Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians.
43. Epidemiology of pineoblastoma in the United States, 2000–2017.
44. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes
45. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome
46. Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors.
47. Germline PTEN promoter mutations and deletions in Cowden/ Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. (Report)
48. Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.
49. Protean PTEN: form and function
50. Choline deficiency--induced liver damage is reversible in [Pemt.sup.-/-] mice. (Nutrient Metabolism -- Research Communication)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.